RE:RE:RE:Stock going to $400USDEmerald being a research company may be a good thing for medicines unknown for cures as well as treatments we don’t know about. Perhaps they have something in their pipeline wich could propel that company forward
the founder in Emerald is no dummie
possibilties are endless
joint ventures make for two teams adding depth overall for both companies